Veramed, a leading provider of biometrics services to the pharmaceutical and biotech industries, today announced a strategic leadership transition as part of its continued global expansion. Founder and current CEO Matthew Jones will step into a new role focused on innovation, while seasoned industry executive Troy McCall has been appointed as the company’s new Chief Executive Officer.This founder-inspired transition is fully supported by Veramed’s leadership team and reflects the company’s commitment to scaling its values-driven culture while meeting the demands of a growing, global client base.
“Veramed is more than operational excellence; it’s also about purpose and impact. I’m eager to lead our innovation efforts and help to shape the future of our industry,” said Matthew Jones.Troy McCall brings a wealth of experience to Veramed, having led multinational organisations of up to 2,000 employees through growth, transformation, and CEO transitions. His previous roles include COO and CEO at Premier Research and COO at CHROMOSOURCE. He holds a PhD in Pharmaceutical Sciences and a BS in Chemistry.
“What drew me to Veramed was its culture – its people-first mindset and unwavering values,” said Troy McCall.Veramed assures clients and partners that this leadership change will not impact the quality or consistency of its services. The company remains committed to delivering the same high standards and collaborative culture that clients have come to trust.
About Veramed
Veramed is a Contract Research Organisation (CRO) dedicated to setting the new standard for end-to-end biometrics. Founded in 2012, the company blends deep statistical, programming and data management expertise with a second to none culture, innovation, automation, and world-class governance to accelerate evidence generation and improve patient outcomes. With teams across the UK, Europe, North America, India, and Ukraine, Veramed ensures high-quality, submission-ready results across Phases I–IV.
As a certified B Corp and 3* accredited by Best Companies, Veramed is committed to excellence, collaboration, and a people-first culture that underpins its reputation for quality and trusted partnerships.
